Concepedia

Publication | Open Access

Erenumab in chronic migraine with medication overuse

212

Citations

21

References

2019

Year

Abstract

This study provides Class II evidence that erenumab reduces monthly migraine days at 3 months in patients with chronic migraine and medication overuse.

References

YearCitations

Page 1